Authors:
Latchman, Y
Wood, CR
Chernova, T
Chaudhary, D
Borde, M
Chernova, I
Iwai, Y
Long, AJ
Brown, JA
Nunes, R
Greenfield, EA
Bourque, K
Boussiotis, VA
Carter, LL
Carreno, BM
Malenkovich, N
Nishimura, H
Okazaki, T
Honjo, T
Sharpe, AH
Freeman, GJ
Citation: Y. Latchman et al., PD-L2 is a second ligand for PD-I and inhibits T cell activation, NAT IMMUNOL, 2(3), 2001, pp. 261-268
Authors:
McAdam, AJ
Chang, TT
Lumelsky, AE
Greenfield, EA
Boussiotis, VA
Duke-Cohan, JS
Chernova, T
Malenkovich, N
Jabs, C
Kuchroo, VK
Ling, V
Collins, M
Sharpe, AH
Freeman, GJ
Citation: Aj. Mcadam et al., Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4(+) T cells, J IMMUNOL, 165(9), 2000, pp. 5035-5040
Authors:
Gaglia, JL
Greenfield, EA
Mattoo, A
Sharpe, AH
Freeman, GJ
Kuchroo, VK
Citation: Jl. Gaglia et al., Intercellular adhesion molecule 1 is critical for activation of CD28-deficient T cells, J IMMUNOL, 165(11), 2000, pp. 6091-6098
Authors:
Sattler, M
Verma, S
Shrikhande, G
Byrne, CH
Pride, YB
Winkler, T
Greenfield, EA
Salgia, R
Griffin, JD
Citation: M. Sattler et al., The BCR/ABL tyrosine kinase induces production of reactive oxygen species in hematopoietic cells, J BIOL CHEM, 275(32), 2000, pp. 24273-24278
Authors:
Stremmel, C
Greenfield, EA
Howard, E
Freeman, GJ
Kuchroo, VK
Citation: C. Stremmel et al., B7-2 expressed on EL4 lymphoma suppresses antitumor immunity by an interleukin 4-dependent mechanism, J EXP MED, 189(6), 1999, pp. 919-930